
Share
A strategic round backed by Black Ops VC and Stanford University values MedHaul's bet that fixing missed appointments through smarter logistics can cut costs and improve outcomes in a fragmented, manual industry.
MedHaul, a B2B platform that coordinates non-emergency medical transport, has closed a $4.1 million strategic round, bringing its total funding to $7 million. Black Ops VC led the round, with participation from Pier 70 Ventures, Seae Ventures, Stanford University, 450 Ventures (the venture arm of BCBS of Alabama), LaunchTN and the American Cancer Society's BrightEdge. The capital will fund expansion into oncology, already 60% of rides booked on the platform, and support a forthcoming integration with Epic.
The investment targets a problem hiding in plain sight. CMS estimates transportation barriers account for a quarter or more of missed clinic appointments nationwide. A 2017 estimate put the annual cost of missed appointments to the U.S. healthcare system at $150 billion. Research published in BMC Medicine has linked missed appointments to higher mortality among patients with chronic conditions. These aren't soft metrics. They translate directly into payer cost, provider revenue loss and patient outcomes, which is why strategic investors like a Blue Cross affiliate and a cancer research nonprofit are at the table.
MedHaul's model is straightforward. Providers and payers use the platform to match patients with transport vendors based on acuity and accommodation needs, whether that's a wheelchair, a stretcher or something more specialized. Care teams can schedule same-day or advance rides, track them in real time, manage billing and flag patients at elevated risk of no-shows. Patients typically pay nothing. The MedHaul client, usually a provider or payer, sponsors rides out of an existing transport budget, or taps a patient's benefit in high-volume specialties.
The existing medical transport ecosystem is, in founder and CEO Erica Plybeah's words, "very antiquated" and "heavily manual." Many transport vendors are small operators without basic digital infrastructure. When MedHaul launched in 2019, some vendors didn't even have a website. Manual coordination between care teams and ride providers can stretch booking times past two hours. MedHaul claims it narrows that to 30 minutes to an hour for same-day standard rides, and two to three hours for higher-acuity cases requiring more complex logistics.
That efficiency gap is the investment thesis in miniature. Fragmented, low-tech markets are ripe for platform consolidation, and healthcare logistics has lagged far behind consumer ride-hailing in sophistication. MedHaul's network now spans 17 states and roughly 600 transport companies, concentrated in cancer, kidney disease, maternal health and behavioral health. It also supports hospital discharges and rural populations, where the access problem is often most acute. Over half of MedHaul's rides require mobility assistance. Forty-two percent of riders live in rural communities. The average rider took eight trips in 2025.
The company reports a 97% ride completion rate, a 25% reduction in missed appointments for providers using the platform, and a 52% improvement in patient appointment timeliness. Those figures, if they hold up at scale, are the kind of outcomes data that payers and health systems need to justify budget allocation. Oncology's dominance on the platform, 60% of rides, makes sense given treatment regimens demand frequent, time-sensitive visits where a missed appointment can delay care with real clinical consequences.

AI is woven through the product rather than bolted on as a marketing layer. MedHaul runs a conversational AI agent for older patients who prefer phone calls over text, deploys AI agents to book rides within seconds for complex cases, and offers care teams a tool called MedHaul GPT for querying program and patient data. Plybeah frames this as a deliberate choice to prioritize implementation over flash. "There has been an explosion in digital health point solutions," she said, "but implementation is a whole different question."
The company also launched an enterprise platform for large health systems and multi-location practices, which integrates with Uber Health so ride-share and non-emergency medical transport bookings sit in one interface, alongside AI-enabled analytics on patient mobility. A newer clinical trial product targets contract research organizations and pharma clients, broadening the addressable market beyond traditional provider and payer relationships.
James Norman, co-founder and managing partner at Black Ops VC, called MedHaul's focus on high-acuity communities and user-friendly design "an attractive investment," noting the firm is "proud to help them scale." That language is standard venture framing, but the underlying bet is specific: AI-enabled logistics tools solving unmet healthcare needs are investable precisely because the inefficiencies are large and measurable.
Plybeah's personal history shapes the company's structure as much as its mission statement. She grew up in the Mississippi Delta, where her grandmother, a diabetic and double-leg amputee, struggled with transportation access to care. That experience, combined with a career spanning clinical and research informatics at Epic Systems and St. Jude Children's Research Hospital, informed MedHaul's founding in 2019. The company is organized as a public benefit corporation and certified B Corp, a structure that legally requires it to pursue a stated public benefit alongside financial returns. It remains a for-profit business, but the dual mandate is meant to attract aligned investors, employees and customers.
MedHaul's $4.1 million raise is modest by healthtech standards, but the strategic investor mix, a Blue Cross affiliate, a cancer nonprofit and a university endowment, signals validation beyond pure financial return. The thesis rests on solid ground: transportation barriers are a documented, costly driver of missed appointments, and MedHaul's reported completion and timeliness metrics suggest real operational traction. The forthcoming Epic integration is the metric to watch next. Plugging into the dominant EHR vendor could meaningfully lower the barrier to adoption for large health systems, turning a point solution into embedded infrastructure. For investors assessing healthtech logistics plays, the combination of a large, quantifiable problem, strategic payer backing and a capital-efficient path to $7 million raised against a focused oncology and rural-health niche makes MedHaul a name worth tracking as it scales toward broader EHR interoperability.
Tags
Original Sources
Medical transport platform MedHaul, focused on high-needs patients, raises $4.1M
↗ https://www.fiercehealthcare.com/digital-health/medical-transport-booking-platform-medhaul-raises-41m-expand
About the author
Marcus began tracking AI's market implications in 2016, noticing AI-related patent filings accelerating ahead of earnings upgrades before most of the sell-side had caught on. A former fixed-income quantitative analyst, he spent two decades building models that priced risk across emerging markets before pivoting to cover the economic impact of AI full-time. His writing translates opaque technical developments into clear risk/reward terms — and he's rarely diplomatic about the gap between AI valuations and underlying fundamentals. He believes most market participants still underestimate AI's long-run deflationary effect on knowledge work.
More from The Analyst →This Week's Edition
13 November 2026
14 articles
Related Articles
Related Articles
More Stories
© 2026 Cedar & Bloom. All rights reserved.